What the study found
The maternal microbiota, meaning the communities of microorganisms in and on the body, is described as an important regulator of pregnancy outcomes and early infant immune programming. The review also reports that maternal-infant microbial transfer during the first 1,000 days is linked to infant gut microbiota establishment and immune development.
Why the authors say this matters
The authors conclude that understanding how microbiota, hormones, and immunity interact may help develop approaches to improve maternal and child health. The study suggests this is relevant because the first 1,000 days are a critical window for infant microbiota establishment and immune programming.
What the researchers tested
This is a review article that synthesizes current findings on maternal-infant microbiome interactions. It discusses changes in gut, vaginal, oral, and putative placental microbial communities across gestation, as well as proposed therapeutic strategies including probiotics, prebiotics, fecal microbiota transplantation, next-generation microbial ecosystem therapeutics, and CRISPR-based approaches.
What worked and what didn't
The review says maternal microbial transitions are associated with pregnancy complications such as gestational diabetes mellitus, preeclampsia, intrahepatic cholestasis of pregnancy, fetal growth restriction, and preterm birth. It also states that delivery, breastfeeding, and early-life exposures can seed the neonatal gut with beneficial taxa such as Bifidobacterium and shape immune tolerance through mediators including IgA, TGF-β, and human milk oligosaccharides. Perturbations such as cesarean delivery, antibiotic exposure, or maternal dysbiosis have been associated with higher later risks of allergy, autoimmunity, obesity, and neurodevelopmental abnormalities.
What to keep in mind
The abstract says evidence for microbial DNA in the placenta and uterus is emerging but debated, and it raises questions about in utero microbial transmission. It also notes major gaps in establishing the existence of a true placental microbiome, understanding maternal immune-microbial signaling, and determining the long-term efficacy of microbiome-targeted therapies.
Key points
- Maternal microbiota is described as an important regulator of pregnancy outcomes and early infant immune programming.
- The review links maternal microbial changes during gestation with gestational diabetes, preeclampsia, intrahepatic cholestasis of pregnancy, fetal growth restriction, and preterm birth.
- Microbial transfer through delivery, breastfeeding, and early-life exposures can seed the neonatal gut with beneficial taxa such as Bifidobacterium.
- The abstract says cesarean delivery, antibiotic exposure, and maternal dysbiosis have been associated with higher later risks of allergy, autoimmunity, obesity, and neurodevelopmental abnormalities.
- Key gaps remain around a true placental microbiome, maternal immune-microbial signaling, and long-term efficacy of microbiome-targeted therapies.
Disclosure
- Research title:
- Maternal microbiota affects pregnancy outcomes and infant immune development
- Authors:
- Muhammad Junaid, Aftab Ahmad, Zeming Hu, Mengyao Xu, Xinyi Shi, Na Qu, Tianyu Du, Huiqing Ding, Yabin Zhu
- Institutions:
- Ningbo University, Hebei Medical University, Fourth Hospital of Hebei Medical University, Ningbo University Affiliated Hospital, Ningbo First Hospital
- Publication date:
- 2026-02-25
- OpenAlex record:
- View
Get the weekly research newsletter
Stay current with peer-reviewed research without reading academic papers — one filtered digest, every Friday.